Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Jazz Pharmaceuticals PLC
Cash from Investing Activities
Jazz Pharmaceuticals PLC
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Cash from Investing Activities
-$163.1m
|
CAGR 3-Years
46%
|
CAGR 5-Years
16%
|
CAGR 10-Years
-26%
|
|
Perrigo Company PLC
NYSE:PRGO
|
Cash from Investing Activities
-$77.5m
|
CAGR 3-Years
26%
|
CAGR 5-Years
9%
|
CAGR 10-Years
28%
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Cash from Investing Activities
-$50.1m
|
CAGR 3-Years
10%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Cash from Investing Activities
-$54.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Cash from Investing Activities
€40.3m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Ovoca Bio PLC
LSE:OVB
|
Cash from Investing Activities
€1.5m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Jazz Pharmaceuticals PLC's Cash from Investing Activities?
Cash from Investing Activities
-163.1m
USD
Based on the financial report for Dec 31, 2023, Jazz Pharmaceuticals PLC's Cash from Investing Activities amounts to -163.1m USD.
What is Jazz Pharmaceuticals PLC's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-26%
Over the last year, the Cash from Investing Activities growth was 63%. The average annual Cash from Investing Activities growth rates for Jazz Pharmaceuticals PLC have been 46% over the past three years , 16% over the past five years , and -26% over the past ten years .